Quick Answer
HEALTHSTREAM INC reported Research And Development Expense of $50.98 million for the year ending 2025.
- HEALTHSTREAM INC showed an increase of +4.3% in Research And Development Expense from 2024 to 2025.
- This data is from HEALTHSTREAM INC's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), HEALTHSTREAM INC's Research And Development Expense has grown by 711.2%.
- Historical annual values: Fiscal year 2025: $50.98 million | Fiscal year 2024: $48.89 million | Fiscal year 2023: $45.54 million | Fiscal year 2022: $44.28 million | Fiscal year 2021: $41.66 million | Fiscal year 2020: $32.31 million | Fiscal year 2019: $29.11 million | Fiscal year 2018: $25.74 million | Fiscal year 2017: $24.15 million | Fiscal year 2016: $24.23 million | Fiscal year 2015: $24.21 million | Fiscal year 2014: $16.46 million | Fiscal year 2013: $11.76 million | Fiscal year 2012: $8.61 million | Fiscal year 2011: $7.47 million | Fiscal year 2010: $6.99 million | Fiscal year 2009: $6.29 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: